Key points are not available for this paper at this time.
The present study defines novel threshold levels for clone size caused by acquired somatic mutations in the CH-driver genes DNMT3A and TET2 that are associated with worse outcome in patients with CHF.
Aßmus et al. (Sat,) studied this question.